Euphora™ EUP22506XRecalls & reported problems
Medtronic, Inc. · BALLOON EUP22506X EUPHORA RX US · Class 2
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 2
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169559936), received between May 13, 2024 and May 13, 2024 — classified as 1 injury.
The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).
2 FDA recall records name this device's identifier, 1 still open.
1 other recall cover devices cleared under the same FDA submission (K143480); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Recalls naming this device
- Sep 3, 2019Open, Classified
Medtronic has determined that some catheters have a slightly higher diameter stylette causing removal difficulties.
Z-0122-2020 · Root cause: Under Investigation by firm · FDA record ↗
- Jul 13, 2017Terminated
Stylette removal difficulties on the Euphora and Solarice products.
Z-3136-2017 · Root cause: Process design · FDA record ↗
Most reported problems
Device problems
- Burst Container or Vessel1
- Detachment of Device or Device Component1
- Device Dislodged or Dislocated1
- Material Deformation1
Patient problems
- Insufficient Information1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMay 13, 2024Burst Container or Vessel; Detachment of Device or Device Component; Device Dislodged or Dislocated; Material Deformation; Burst Container or Vessel; Detachment of Device or Device Component; Device Dislodged or Dislocated; Material Deformation
DURING A PROCEDURE AN ATTEMPT WAS MADE TO USE ONE EUPHORA RX BALLOON CATHETER TO TREAT A MODERATELY TORTUOUS, SEVERELY CALCIFIED LESION EXHIBITING 80-85% STENOSIS LOCATED IN THE MID LEFT ANTERIOR DESCENDING (LAD) ARTERY. THE DEVICE WAS INSPECTED WITH NO ISSUES NOTED. NEGATIVE PREP WAS PERFORMED WITH NO ISSUES NOTED. THE LESION WAS PRE-DILATED. THE DEVICE DID PASS THROUGH A PREVIOUSLY DEPLOYED STENT. EXCESSIVE FORCE WAS NOT USED DURING DELIVERY. THE DEVICE WAS NOT KINKED AND RESTRAIGHTENED DURING USE. IT WAS REPORTED THAT THE DEVICE DETACHED, CRACKED, OR FRACTURED AT THE BALLOON. IT WAS ALSO REPORTED THAT THE EUPHORA BALLOON WAS INFLATED TO NOMINAL PRESSURE AND IT RUPTURED DUE TO PLAQUE IN THE VESSEL. THE BALLOON CATHETER WAS REMOVED AND IT WAS NOTED THAT THE BALLOON MARKERS AND BALLOON WERE STILL IN THE PATIENT. THE MARKERS AND BALLOON COULD BE SEEN UNDER FLUOROSCOPY. ANOTHER BALLOON WAS USED ALONG WITH A NON-MEDTRONIC GUIDE EXTENSION CATHETER TO TRAP THE DETACHED EUPHORA BALLOON. THE PATIENT IS REPORTED TO BE ALIVE WITH NO FURTHER INJURY.
Patient problems: Insufficient Information
MAUDE report 19297500 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K143480. One submission often covers many models, so check the product and lot details in each record.
- Z-3137-2017 · Jul 13, 2017 · TerminatedSolarice Rapid Exchange Balloon Dilatation Catheter, a Percutaneous Transluminal Coronary Angioplasty (PTCA) Rapid Exchange System.
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.